CA Patent

CA3071182A1 — Cholestyramine pellets, oral cholestyramine formulations and use thereof

Assigned to Albireo AB · Expires 2019-02-14 · 7y expired

What this patent protects

The invention relates to small pellets comprising cholestyramine. The pellets have a high cholestyramine content and are stable enough to be coated with one or more coating layers. The invention also relates to amultiparticulate drug delivery system comprising such pellets.The in…

USPTO Abstract

The invention relates to small pellets comprising cholestyramine. The pellets have a high cholestyramine content and are stable enough to be coated with one or more coating layers. The invention also relates to amultiparticulate drug delivery system comprising such pellets.The invention further relates to an oral formulation for targeted delivery of cholestyramine to the colon, comprising a plurality of cholestyramine pellets that are coated with a colon releasecoating. The invention also relates to the use of this formulation in the treatment of bile acid malabsorption and bile acid diarrhoea.

Drugs covered by this patent

Patent Metadata

Patent number
CA3071182A1
Jurisdiction
CA
Classification
—
Expires
2019-02-14
Drug substance claim
No
Drug product claim
No
Assignee
Albireo AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.